Board of Directors
Darryl Mitteldorf, LCSW
Mr. Mitteldorf is an oncology social worker and the founder of the national men’s cancer survivor support and advocacy nonprofit organization, Malecare. Mr. Mitteldorf is also the founder and Executive
Director of the National LGBT Cancer Project.
Mr. Mitteldorf is an innovator of patient centered program design. He created several of the earliest online cancer survivor support communities and medical information websites. Mr. Mitteldorf is the creator of the symptom and side effect tracker and data collecting mobile app, Cancergraph. He also earned a patent for inventing a radiation treatment quality assurance and data collecting device and method.
Mr. Mitteldorf is a leading and founding scholar of the study of gay, lesbian, bisexual and transgender psycho-oncology. He has written and published articles in peer-reviewed and popular journals and has lectured and presented research at numerous conferences. As a social worker, Mr. Mitteldorf has led nearly 2,000 prostate cancer support group meetings since 1997. He is a national advocate and policy analyst for patient rights, focusing on underserved communities, quality of life and affordable access to health care.
Mr. Mobilio is a renowned poet who has been powerfully active in health care advocacy. Mr. Mobilio is the recipient of a Whiting Writer’s Award (2000) and the National Book Critics Circle award for excellence in reviewing (1999). His poetry, fiction, and criticism have appeared in Harper’s, The Village Voice, Grand Street, PEN America,Cabinet, Bomb, Tin House, Fence, The Brooklyn Rail, The New York Times Book Review, and Black Clock. His books of poetry include Bendable Siege, The Geographics, Me with Animal Towering, and Touch Wood. He is an Assistant Professor of Literary Studies at the New School’s Eugene Lang College and the co-editor of Bookforum. Mr. Mobilio holds degrees from Penn State University.
Mr. Oz is a leading technology entrepreneur and noted computer systems and programming consultant. Mr. Oz is a widely acknowledged leader in bio-medical technology development. Mr. Oz had been president of BitMa-gix, a New York-based division of American Security Designs. He holds degrees from Yale University and Swarthmore College.
Vincent Santillo, MD
Dr. Santillo is an Internal Medicine Resident – PGY2 at the New York University Langone Medical Center. Dr. Santillo has written several peer reviewed articles and book chapters on Prostate Cancer treatment. He is a graduate of the Columbia University College of Physicians and Surgeons and holds an MBA from Columbia University and a BS in Economics from the University of Pennsylvania, Wharton School of Business. Dr Santillo was diagnosed and treated for prostate cancer at age 33.
Mr. Shenitz is a writer, editor, and information professional living in New York. He was formerly the deputy editor of Out magazine, and before that, a reporter at Newsweek for more than 10 years. Mr. Shenitz holds degrees from Yale University. His partner of 20 years–and husband of one year–died of leukemia in February 2011.
Mr. Sheppard is a internationally respected electric power generation consultant. Mr. Sheppard was diagnosed with locally advanced prostate cancer in 2009 and is widely known as a national prostate cancer advocate. Mr. Shepard holds engineering degrees from University of Missouri and Carnegie-Mellon University.
Board of Advisors
Thomas O. Blank, PhD
Department of Human Development and Family Studies, University of Connecticut
Dr, Blank is a social psychologist, focusing on the psychosocial of cancer, aging, masculinity and GLBT health issues. Dr. Blank has also written about his own journey as a prostate cancer survivor. Dr. Blank earned his Ph. D. in Psychology from Columbia University.
President Emeritus, John Simon Guggenheim Foundation, former president, PEN American Center, former dean, University of Pennsylvania and one of America’s leading philanthropists and literary scholars.
David Latini, PhD
Dr. Latini is a clinical health psychologist, focusing on cancer survivorship and symptom management for persons living with genitourinary cancer. He completed his PhD in educational psychology at Stanford University and then completed a respecialization diploma in clinical psychology at California School of Professional Psychology. He written about psycho-social aspects of men diagnosed with prostate cancer and has recently published research regarding quality of life issues for gay men diagnosed with prostate cancer.
Franklyn Lowe, M.D., M.P.H.
Associate Director, Department of Urology, St. Luke’s-Roosevelt Medical Center, New York
Dr. Lowe was previously Chairman of the American Urological Association (AUA) Complementary and Alternative Medicine Committee (2001-2009) as well as a member of the Benign Prostatic Hyperplasia (BPH) Guidelines Committee (1996-2003) and By-Laws Committee (1993-2001). He is currently on the Expert Panel of the Communications Committee of the AUA. Dr. Lowe is also a member of the New York Section of the AUA (executive board member), New York Academy of Medicine (former President of the Section on Urology), New York State Urological Association, American Association of Clinical Urologists, and the Société Internationale d’Urologie.
Daniel Shasha, M.D
Attending, Department of Radiation Oncology, Beth Israel Medical Center, New York
Dr. Shasha is an expert in cancers of the male genitourinary tract, with a specific focus on treatment of prostate cancer. He has extensive experience using 3-dimensional conformal radiotherapy, permanent radioactive seed implants and temporary high dose rate implants of the prostate. Dr. Shasha is leader of the Beth Israel Comprehensive Prostate Cancer Program, which allows men to discuss their treatment options in a dual consultation with a radiation oncologist and a urologic oncologist simultaneously.
Joseph Wagner, M.D.
Director, Robotic Surgery Program, Hartford Hospital, Connecticut
Dr. Wagner is a pioneer in robotic surgery, performing some of the first cases in 2001. He performs minimally invasive surgery for virtually all urologic cancers. He was the physician in charge of urologic oncology at Beth Israel Medical Center, NY, NY from 1997-2003. Dr. Wagner joined the Hartford Hospital Medical Staff in 2003 and performed the first robotic surgery in CT in December of that year.
Darryl Mitteldorf, LCSW Executive Director
Keith Morton, Director, Black Dad Connection Program
Joel Nowak, MSW Director, Advanced Prostate Cancer Program
Gerald Perlman, Ph.D. Program Director, Special Services
Malecare is a highly professional, nonhierarchical and lean organization, which values diversity and commitment to the issues and results. Malecare is looking for licensed social workers and psychologists with strong clinical skills, an open mindset, and proven applied intelligence. C.V. and letter may be sent via e-mail to email@example.com .